Drugs policy in developing countries:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
London u.a.
Zed Books
1992
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XII, 136 S. |
| ISBN: | 1856490599 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV008269984 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 931013s1992 |||| 00||| engod | ||
| 020 | |a 1856490599 |9 1-85649-059-9 | ||
| 035 | |a (OCoLC)26761437 | ||
| 035 | |a (DE-599)BVBBV008269984 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 | ||
| 050 | 0 | |a RA401.D44 | |
| 082 | 0 | |a 362.1/782/091724 |2 20 | |
| 245 | 1 | 0 | |a Drugs policy in developing countries |c Najmi Kanji ... |
| 264 | 1 | |a London u.a. |b Zed Books |c 1992 | |
| 300 | |a XII, 136 S. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 7 | |a Beleid |2 gtt | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 4 | |a Entwicklungsländer | |
| 650 | 4 | |a Developing Countries | |
| 650 | 4 | |a Drug Industry | |
| 650 | 4 | |a Drug Utilization | |
| 650 | 4 | |a Drug utilization |z Developing countries | |
| 650 | 4 | |a Health Policy | |
| 650 | 4 | |a Pharmaceutical policy |z Developing countries | |
| 650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |2 gnd |9 rswk-swf |
| 651 | 7 | |a Entwicklungsländer |0 (DE-588)4014954-7 |2 gnd |9 rswk-swf | |
| 689 | 0 | 0 | |a Entwicklungsländer |0 (DE-588)4014954-7 |D g |
| 689 | 0 | 1 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |D s |
| 689 | 0 | 2 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Kanji, Najmi |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005463242&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-005463242 | ||
Datensatz im Suchindex
| _version_ | 1804122665727819776 |
|---|---|
| adam_text | Contents
Tables and Figures vi
Contributors vii
Foreword and Acknowledgements ix
Acronyms and Abbreviations xi
1 Early Initiatives in Essential Drugs Policy
Masuma Mamdani 1
Drugs and Health in Developing Countries 1
The Domination by the Transnational Drugs Industries 3
Chaos Turns to Tragedy 5
Drugging the Americas 7
The Response of the Third World 8
The Search for a Way Forward 11
The World Health Organization 12
Cooperation with other UN Agencies 14
A Coordinated UN Response 16
The Industry s Response 17
Conclusion 19
2 Formulating an Essential Drugs Policy: WHO s Role
Gill Walt and Jan Willem Harnmeijer 24
WHO s Structure and Policy Processes 24
Getting Essential Drugs on to the Policy Agenda 26
The Period of Policy Exploration 1977 1981 27
Setting the Priorities: 1981 1983 28
Advocacy and Action: 1983 1988 33
Policy Drift: 1988 1990 42
iii
3 Consumers versus Producers:
Power Play Behind the Scenes
Anita Hardon 48
Introduction 48
The Early Years of DAP 49
Calling for a Code on Pharmaceutical Marketing 50
Heightened Politicization: The Industry on the Defensive 52
The Nairobi Conference: 1985 55
The Revised Drugs Strategy 58
More Emphasis on National level Implementation: 1986 90 60
In Conclusion 62
4 Action at Country Level:
The International and National Influences
NajmiKanji 65
Components of a Rational Drugs Policy 65
International Drug Companies 69
The World Health Organization 74
Donors 76
UNICEF 78
The National Connection 79
5 What Has Been Achieved and Where Are We Now?
NajmiKanji and Anita Hardon 91
Essential Drugs Lists 91
Essential Drugs Programmes 93
The Availability of Essential Drugs 96
The Rational Use of Drugs 98
Assessing Rational Drugs Use 98
Self medication: A Constraint to the Success of EDPs 100
The Irrationality of Diarrhoea Treatment 101
Antibiotic Misuse: Far reaching Consequences 102
Rationality in a Socio cultural Perspective 102
Have 15 Years of Essential Drugs Achieved Anything? 103
iv
6 New Horizons in the 1990s
Anita Hardon andNajmi Kanji 110
The Leadership Role of WHO Diminishes 110
Pharmaceutical Cost Recovery and Structural Adjustment 113
The Rational Use of Drugs: Focus for the 1990s 115
AIDS and Increasing Demands for Drugs 117
The Rational Use of Contraceptives: Free Choice? 118
Rationalizing the Private Sector: The Industry s Role 119
In Conclusion 123
Appendix 128
Index 133
v
Tables and Figures
Tables
2.1 DAP: Financial Resources (1980 9) for Global and
Interregional Activities 34
2.2 Staffing Levels of DAP, Geneva 35
5.1 The Drugs Market from 13 Country Case Studies 92
5.2 Distribution of Essential Drugs to Primary Level Services 97
Figures
5.1 Countries with Essential Drugs Lists, 1983 9 92
5.2 Countries with Operational Essential Drugs
Programmes, 1983 and 1989 93
vi
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV008269984 |
| callnumber-first | R - Medicine |
| callnumber-label | RA401 |
| callnumber-raw | RA401.D44 |
| callnumber-search | RA401.D44 |
| callnumber-sort | RA 3401 D44 |
| callnumber-subject | RA - Public Medicine |
| ctrlnum | (OCoLC)26761437 (DE-599)BVBBV008269984 |
| dewey-full | 362.1/782/091724 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.1/782/091724 |
| dewey-search | 362.1/782/091724 |
| dewey-sort | 3362.1 3782 591724 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01751nam a2200481 c 4500</leader><controlfield tag="001">BV008269984</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">931013s1992 |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1856490599</subfield><subfield code="9">1-85649-059-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)26761437</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV008269984</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RA401.D44</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.1/782/091724</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs policy in developing countries</subfield><subfield code="c">Najmi Kanji ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London u.a.</subfield><subfield code="b">Zed Books</subfield><subfield code="c">1992</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XII, 136 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Beleid</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Entwicklungsländer</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Developing Countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Utilization</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug utilization</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield><subfield code="z">Developing countries</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelversorgung</subfield><subfield code="0">(DE-588)4140783-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Entwicklungsländer</subfield><subfield code="0">(DE-588)4014954-7</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Arzneimittelversorgung</subfield><subfield code="0">(DE-588)4140783-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kanji, Najmi</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005463242&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-005463242</subfield></datafield></record></collection> |
| geographic | Entwicklungsländer (DE-588)4014954-7 gnd |
| geographic_facet | Entwicklungsländer |
| id | DE-604.BV008269984 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-09T17:17:29Z |
| institution | BVB |
| isbn | 1856490599 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-005463242 |
| oclc_num | 26761437 |
| open_access_boolean | |
| owner | DE-12 |
| owner_facet | DE-12 |
| physical | XII, 136 S. |
| publishDate | 1992 |
| publishDateSearch | 1992 |
| publishDateSort | 1992 |
| publisher | Zed Books |
| record_format | marc |
| spelling | Drugs policy in developing countries Najmi Kanji ... London u.a. Zed Books 1992 XII, 136 S. txt rdacontent n rdamedia nc rdacarrier Beleid gtt Geneesmiddelen gtt Entwicklungsländer Developing Countries Drug Industry Drug Utilization Drug utilization Developing countries Health Policy Pharmaceutical policy Developing countries Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Arzneimittelversorgung (DE-588)4140783-0 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 gnd rswk-swf Entwicklungsländer (DE-588)4014954-7 g Arzneimittelversorgung (DE-588)4140783-0 s Gesundheitspolitik (DE-588)4113743-7 s DE-604 Kanji, Najmi Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005463242&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Drugs policy in developing countries Beleid gtt Geneesmiddelen gtt Entwicklungsländer Developing Countries Drug Industry Drug Utilization Drug utilization Developing countries Health Policy Pharmaceutical policy Developing countries Gesundheitspolitik (DE-588)4113743-7 gnd Arzneimittelversorgung (DE-588)4140783-0 gnd |
| subject_GND | (DE-588)4113743-7 (DE-588)4140783-0 (DE-588)4014954-7 |
| title | Drugs policy in developing countries |
| title_auth | Drugs policy in developing countries |
| title_exact_search | Drugs policy in developing countries |
| title_full | Drugs policy in developing countries Najmi Kanji ... |
| title_fullStr | Drugs policy in developing countries Najmi Kanji ... |
| title_full_unstemmed | Drugs policy in developing countries Najmi Kanji ... |
| title_short | Drugs policy in developing countries |
| title_sort | drugs policy in developing countries |
| topic | Beleid gtt Geneesmiddelen gtt Entwicklungsländer Developing Countries Drug Industry Drug Utilization Drug utilization Developing countries Health Policy Pharmaceutical policy Developing countries Gesundheitspolitik (DE-588)4113743-7 gnd Arzneimittelversorgung (DE-588)4140783-0 gnd |
| topic_facet | Beleid Geneesmiddelen Entwicklungsländer Developing Countries Drug Industry Drug Utilization Drug utilization Developing countries Health Policy Pharmaceutical policy Developing countries Gesundheitspolitik Arzneimittelversorgung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=005463242&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT kanjinajmi drugspolicyindevelopingcountries |